(NASDAQ: HOOK) Hookipa Pharma's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.37%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.28%.
Hookipa Pharma's earnings in 2025 is -$43,503,000.On average, 1 Wall Street analyst forecast HOOK's earnings for 2025 to be -$31,353,501, with the lowest HOOK earnings forecast at -$31,353,501, and the highest HOOK earnings forecast at -$31,353,501. On average, 1 Wall Street analyst forecast HOOK's earnings for 2026 to be -$18,812,101, with the lowest HOOK earnings forecast at -$18,812,101, and the highest HOOK earnings forecast at -$18,812,101.
In 2027, HOOK is forecast to generate -$15,073,799 in earnings, with the lowest earnings forecast at -$15,073,799 and the highest earnings forecast at -$15,073,799.